BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28303729)

  • 1. Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
    Majd P; O'Connell DE; Kim RC; Bota DA; Carrillo JA
    CNS Oncol; 2017 Apr; 6(2):89-94. PubMed ID: 28303729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.
    O'Connell D; Shen V; Loudon W; Bota DA
    CNS Oncol; 2017 Jan; 6(1):11-18. PubMed ID: 27918194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
    J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
    Omar AI
    J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
    Schwartz MA; Onuselogu L
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
    Saria MG; Kesari S
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
    Rehman AA; Elmore KB; Mattei TA
    Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor treating fields in pediatric high-grade glioma.
    Green AL; Mulcahy Levy JM; Vibhakar R; Hemenway M; Madden J; Foreman N; Dorris K
    Childs Nerv Syst; 2017 Jul; 33(7):1043-1045. PubMed ID: 28470383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Treating Fields in Neuro-Oncological Practice.
    Mrugala MM; Ruzevick J; Zlomanczuk P; Lukas RV
    Curr Oncol Rep; 2017 Aug; 19(8):53. PubMed ID: 28664468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality.
    Wong ET; Lok E; Swanson KD
    Prog Neurol Surg; 2018; 32():180-195. PubMed ID: 29990984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
    Kim EH; Kim YH; Song HS; Jeong YK; Lee JY; Sung J; Yoo SH; Yoon M
    Oncotarget; 2016 Sep; 7(38):62267-62279. PubMed ID: 27556699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.
    McClelland S; Henrikson CA; Ciporen JN; Jaboin JJ; Mitin T
    World Neurosurg; 2018 Nov; 119():58-60. PubMed ID: 30064027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin toxicities associated with tumor treating fields: case based review.
    Lukas RV; Ratermann KL; Wong ET; Villano JL
    J Neurooncol; 2017 Dec; 135(3):593-599. PubMed ID: 28849343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.
    Lok E; Swanson KD; Wong ET
    Expert Rev Med Devices; 2015; 12(6):717-26. PubMed ID: 26513694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
    Mirza FA; Shamim MS
    J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor treating fields: a new standard treatment for glioblastoma?
    Taillibert S; Le Rhun E; Chamberlain MC
    Curr Opin Neurol; 2015 Dec; 28(6):659-64. PubMed ID: 26551239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J; Wong ET
    Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of tumor treating fields therapy for high-grade gliomas.
    Shah PP; White T; Khalafallah AM; Romo CG; Price C; Mukherjee D
    J Neurooncol; 2020 Jul; 148(3):433-443. PubMed ID: 32578135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour Treating Fields (TTFs) for Paediatric Brain Tumours, Brain Metastases and other Novel Applications.
    Mirza FA; Shamim MS
    J Pak Med Assoc; 2018 Nov; 68(11):1729-1731. PubMed ID: 30410163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.